Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3029% below fair value
$61.10+0.56 (+0.93%)
Close on Nov 13, 2026Market cap $1.77BP/E 17.8Yield –
Inspire Medical Systems gross margin
Gross margin is gross profit as a percentage of revenue.
Inspire Medical Systems's gross margin for the twelve months ending Sep 30, 2026 was 86.2%. For fiscal 2025 it was 85.4%, against 84.7% the year before. The highest annual figure on record is 85.7% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 85.4% | +0.7 |
| FY2024 | Dec 31, 2024 | 84.7% | +0.1 |
| FY2023 | Dec 31, 2023 | 84.5% | +0.8 |
| FY2022 | Dec 31, 2022 | 83.8% | −2.0 |
| FY2021 | Dec 31, 2021 | 85.7% | +1.0 |
| FY2020 | Dec 31, 2020 | 84.7% | +1.4 |
| FY2019 | Dec 31, 2019 | 83.4% | +3.2 |
| FY2018 | Dec 31, 2018 | 80.1% | +1.2 |
| FY2017 | Dec 31, 2017 | 78.9% | +2.7 |
| FY2016 | Dec 31, 2016 | 76.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 86.0% | +0.2 |
| Q2 FY2026 | Jun 30, 2026 | 85.5% | +1.5 |
| Q1 FY2026 | Mar 31, 2026 | 86.5% | +1.7 |
| Q4 FY2025 | Dec 31, 2025 | 86.6% | +1.6 |
| Q3 FY2025 | Sep 30, 2025 | 85.8% | +1.8 |
| Q2 FY2025 | Jun 30, 2025 | 84.0% | −0.7 |
| Q1 FY2025 | Mar 31, 2025 | 84.7% | −0.2 |
| Q4 FY2024 | Dec 31, 2024 | 85.0% | −0.4 |
| Q3 FY2024 | Sep 30, 2024 | 84.1% | −0.0 |
| Q2 FY2024 | Jun 30, 2024 | 84.8% | +0.8 |
| Q1 FY2024 | Mar 31, 2024 | 84.9% | +0.5 |
| Q4 FY2023 | Dec 31, 2023 | 85.4% | +1.5 |
| Q3 FY2023 | Sep 30, 2023 | 84.1% | +2.2 |
| Q2 FY2023 | Jun 30, 2023 | 83.9% | −0.5 |
| Q1 FY2023 | Mar 31, 2023 | 84.4% | −1.1 |
| Q4 FY2022 | Dec 31, 2022 | 83.9% | −1.8 |
| Q3 FY2022 | Sep 30, 2022 | 81.9% | −4.1 |
| Q2 FY2022 | Jun 30, 2022 | 84.5% | −1.3 |
| Q1 FY2022 | Mar 31, 2022 | 85.6% | +0.4 |
| Q4 FY2021 | Dec 31, 2021 | 85.8% | +1.3 |
| Q3 FY2021 | Sep 30, 2021 | 86.0% | +0.6 |
| Q2 FY2021 | Jun 30, 2021 | 85.8% | +1.8 |
| Q1 FY2021 | Mar 31, 2021 | 85.2% | +0.6 |
| Q4 FY2020 | Dec 31, 2020 | 84.4% | +0.2 |
| Q3 FY2020 | Sep 30, 2020 | 85.5% | +2.0 |
| Q2 FY2020 | Jun 30, 2020 | 84.0% | +1.1 |
| Q1 FY2020 | Mar 31, 2020 | 84.6% | +2.1 |
| Q4 FY2019 | Dec 31, 2019 | 84.2% | +3.5 |
| Q3 FY2019 | Sep 30, 2019 | 83.4% | +2.3 |
| Q2 FY2019 | Jun 30, 2019 | 82.8% | +2.1 |
| Q1 FY2019 | Mar 31, 2019 | 82.4% | +5.3 |
| Q4 FY2018 | Dec 31, 2018 | 80.7% | −0.4 |
| Q3 FY2018 | Sep 30, 2018 | 81.1% | +2.6 |
| Q2 FY2018 | Jun 30, 2018 | 80.8% | +3.6 |
| Q1 FY2018 | Mar 31, 2018 | 77.2% | −0.3 |
| Q4 FY2017 | Dec 31, 2017 | 81.1% | – |
| Q3 FY2017 | Sep 30, 2017 | 78.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 77.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 77.4% | – |
See a number that looks wrong?